Nicolas Ortonne’s Neurofibromatosis and Lymphoma oncogenesis – NFL team, partner in the SPRINT project, winner of the 6th wave of the RHU call for projects

The SPRINT project (Synergie Pour Accélérer l’INnovation Thérapeutique dans les lymphomes T cutanés – Synergy to Accelerate Therapeutic Innovation in Cutaneous T-cell Lymphoma) was selected in the 6th round of calls for university hospital research projects launched by the French National Research Agency (ANR).

This project brings together several private partners and research teams, including that of Nicolas Ortonne, who will be coordinating the “AI to predict outcome in CTCL” section. Nicolas Ortonne and Jérôme Giustiniani, a member of the NFL team, are also involved in a major section concerning the validation of new therapeutic targets in CTCL (Cutaneous T-cell lymphoma).

This funding of €9,664,690 over 5 years will be shared between all the partners.

More info